Advanced Therapies

Advanced Fluid Management for ATMPs

By providing modular standards and highly customizable solutions, we support you in writing a new chapter in advanced therapy medicinal products (ATMPs): Our single-use technologies and sterile consumables come with the flexibility required for fast turnaround times in advanced therapeutic approches for the areas of controlled freezing & thawing, product aliquotation & filtration and all required logistic steps.

RoSS.FILL CGT_Product photo (26 von 26)

Advanced Fluid Management for Cell and Gene Therapies

Cell and Gene Therapies have specific requirements during cold chain and fluid management processes. They require careful handling in order to prevent product loss or other downfalls in product quality.

Learn more about our product solutions optimized for application in Cell Therapies, Gene Therapies and Gene-Modified Cell Therapies.

Cell therapy fluid management solutions around single-use technologies by Single Use Support

Cell Therapies

Fluid Management Solutions around Single-Use Technologies for Cell Therapies Applications | Autologous Cell Therapy | Allogeneic Cell Therapy 

More information
Gene therapy fluid management solutions around single-use technologies by Single Use Support

Gene Therapies

Fluid Management Solutions around Single-Use Technologies for Gene Therapies |Primary Packaging | Fill & Drain | Freeze & Thaw | Transport | Gene therapy solutions

More information
Gene modified cell therapy fluid management solutions around single-use technologies by Single Use Support

Gene-Modified Cell Therapy

Gene-modified Cell Therapies enable unique approaches to novel treatments, including CAR-T therapies. After collection of cells from patients the genes are edited ex vivo to boost their function and persistence before they are re-administered into the patients body. 

More information

Advanced Fluid Management for Viral Vectors & Plasmid DNA (pDNA)

viral vectors gene therapy 3 aav

Viral Vectors

With the discovery of new fields of application for viral vectors in gene therapy comes an increased need for dedicated solutions along their supply chain

More information
Inlay for vials_Schaumstoff_frozen (7)

Plasmid DNA (pDNA)

Plasmid DNA (pDNA) is used as a starting material for the production of mRNA, most commonly known in the context of COVID-19 vaccines. In addition, pDNA is used at the staring point of producing viral vectors, such as AAVs (Adeno-Associated Virus Vectors) and Lentiviral Vectors.

More information